Clinical Trials › NCT05605782
Active, Not Recruiting
A Post-Authorization, Long-term Study of Ozanimod Real-world Safety
Sponsored by Bristol-Myers Squibb
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 9000
Target enrollment
1
U.S. states
Sep 2021
Start date
Jul 2033
Expected completion
Conditions studied
Multiple Sclerosis, Relapsing-Remitting
Where this trial is running (1 site)
Maryland1 site
Bethesda
MS centers in Maryland
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Maryland centersCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
